BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that there is significant information regarding our new venture on the company's Commodity Vault website found at http://commodityvault.app and we also have 1 physical app found in the Apple App Store and the Google App Store
WOODLAND HILLS, CA / ACCESSWIRE / July 29, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that there is significant information regarding our new venture on the company's Commodity Vault website found at http://commodityvault.app and we also have 1 physical app found in the Apple App Store and the Google App Store (COMMODITY VAULT). This app is available to download right now on both platforms, at no cost to you.
Commodity Vault is a tokenization platform with the goal of creating new investment opportunities, while providing helpful capital options to mining and commodity driven companies. Our app turn real-world commodities like gold, gems, and metals into digital tokens, which can then be purchased, traded, or sold 24 hr/day in 173 countries. We provide the infrastructure to facilitate these transactions. We create significant opportunities for companies by establishing the capacity to use a fixed asset, converted into multiple digital tokens that generate capital. By creating fractional ownership, investors can expand their portfolio with verifiable and credible assets existing on the blockchain.
According to Anthony K. Miller, CEO, "The concept of Real-World Asset Tokenization is a unique and intricate concept, and that is why I chose to introduce our venture, to you, in multiple press releases and videos (a soft launch). We have already created the support infrastructure, and we will continue building components to have a successful enterprise (there is still much work to do). Our tokenization platform offers investment opportunities for investors, while providing helpful capital options to mining companies. Our app turns project real-world commodities into digital tokens thereby creating fractional ownership to investors. Investors can now expand their portfolio with more reliable assets. Our hope is that you immediately download our app and give them a whirl… our app already contain 5 tokenized products (BMCS stock, Calcium, Rhodium, RMC and Carbon Credits) and I also invite you to download and the NovaX wallet so that you can turn your USD into Ethereum and make transaction inside of our app. Capital produced as a result of these transactions provide us with necessary capital to execute different components of our business plan. This app also provides a platform for other companies looking to do the same. Real-World Asset Tokenization is a novel concept, for many different companies especially BMCS. With limited space in this press release I will ultimately do more press, videos and Zoom calls to help you better understand the complexities of this amazing concept commented Miller"
About BioTech Medics, Inc.: BioTech Medics, Inc. (website http://bmcs.company) is a publicly traded Wyoming company traded on the OTC Markets (under the stock symbol BMCS) located in the Los Angeles, California area. Management decided to take the Company back to its biotech roots and did initiate an agreement with certain asset holders in the Dominican Republic with Calcium carbonate reserves. On September 28, 2023 as a result of a negotiated agreement, BioTech Medics received 2 million metric tons of very high quality (99.8% pure) calcium carbonate to market to a worldwide marketplace. This calcium carbonate has a base value of $30 million dollars. Management did procure (along with this transaction) an option to acquire an additional 48 million metric tons of calcium carbonate at a similar transaction value. Our new business plan is an old school commodities plan where we mine our calcium, put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. BMCS is not a Financial Services Company; and Management suggest that potential investors should not use the Companies digital assets, currently on our books. as a calculation to invest in BMCS.
Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbour provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.
These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
CONTACT INFORMATION
INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)\
EMAIL: biotecsmedics@gmail.com
WEBSITE: http://bmcs.company
WEBSITE: http://commodityvault.app
PHONE: 800.988.3782
LOCATION: WOODLAND HILLS, CA.
Contact Information
ANTHONY MILLER
PRES/CEO
tonymillertmiller@gmail.com
6615440275
Related Images
SOURCE: BIOTECH MEDICS INC
View the original press release on accesswire.com
